Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Omnicell (OMCL) Asset Writedowns and Impairment (2016 - 2024)

Omnicell (OMCL) has disclosed Asset Writedowns and Impairment for 10 consecutive years, with -$5.4 million as the latest value for Q4 2024.

  • On a quarterly basis, Asset Writedowns and Impairment rose 20.7% to -$5.4 million in Q4 2024 year-over-year; TTM through Dec 2025 was -$5.4 million, a N/A change, with the full-year FY2023 number at $1.0 million, changed N/A from a year prior.
  • Asset Writedowns and Impairment was -$5.4 million for Q4 2024 at Omnicell, down from -$7000.0 in the prior quarter.
  • In the past five years, Asset Writedowns and Impairment ranged from a high of $7.8 million in Q1 2023 to a low of -$6.8 million in Q4 2023.
  • A 3-year average of $107444.4 and a median of $300000.0 in 2022 define the central range for Asset Writedowns and Impairment.
  • Biggest YoY gain for Asset Writedowns and Impairment was 345.81% in 2023; the steepest drop was 25.94% in 2023.
  • Omnicell's Asset Writedowns and Impairment stood at -$5.4 million in 2022, then dropped by 25.94% to -$6.8 million in 2023, then rose by 20.7% to -$5.4 million in 2024.
  • Per Business Quant, the three most recent readings for OMCL's Asset Writedowns and Impairment are -$5.4 million (Q4 2024), -$7000.0 (Q3 2024), and $5.4 million (Q2 2024).